FlashCell
Latest round
- Seed
Last raised
- Dec 2016
Total raised
- $0.8M
Investors
- 1
About FlashCell
Funded in 2016 and based in Toulouse, France, FlashCell, a spin-off of Vectalys, is a gene therapy company that focuses on developing therapeutic applications for the treatment of various diseases. In May 2018, FlashCell was acquired by Flash Therapeutics. The firm employs its proprietary, non-integrative LentiFlashTM technology that delivers RNA-based therapeutics facilitated by genetic material transfer into the genomic DNA of target cells. The platform targets and cures disease areas such as cancer, and viral or genetic diseases by developing innovative treatments mediated by RNA delivery.
Who invested in FlashCell
1 investor across 1 round
See all investors in FlashCell
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Dec 23, 2016
Amount
$0.8M
Investors
Questions about FlashCell
Who invested in FlashCell?
FlashCell has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has FlashCell raised?
FlashCell has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did FlashCell last raise money?
FlashCell's most recent round on record is a Seed, in Dec 2016.
What does FlashCell do?
Funded in 2016 and based in Toulouse, France, FlashCell, a spin-off of Vectalys, is a gene therapy company that focuses on developing therapeutic applications for the treatment of various diseases.
Where is FlashCell headquartered?
FlashCell is headquartered in Toulouse, France.
Which VCs invest in companies like FlashCell?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at FlashCell's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like FlashCell? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.